ChartRow logo
ChartRow
Stocks and ETFs

financial statements

The full income statement, balance sheet, and cash-flow statement for Occidental Petroleum Corporation (OXY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

See the live OXY chart & snapshot →

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
21.6B
YoY-5.0%
22.7B
YoY-2.2%
23.2B
YoY-35.9%
36.2B
YoY+39.6%
26.0B
YoY+51.5%
Cost of revenue
3.12B
YoY+0.2%
3.12B
YoY-4.8%
3.27B
YoY+18.1%
2.77B
YoY+15.1%
Selling, general & administrative
986M
YoY+2.7%
960M
YoY-2.7%
987M
YoY+4.4%
945M
YoY+9.5%
863M
YoY-0.1%
Other non-operating income
76.0M
YoY-90.0%
759M
YoY+78.2%
426M
YoY-61.6%
1.11B
YoY+47.4%
753M
YoY+1520.8%
Equity-method income
76.0M
YoY-90.0%
759M
YoY+78.2%
426M
YoY-46.3%
793M
YoY+25.7%
631M
YoY+70.5%
Pre-tax income
3.13B
YoY-22.3%
4.02B
YoY-13.7%
4.66B
YoY-67.0%
14.1B
YoY+281.0%
3.71B
YoY+123.6%
Income tax
1.02B
YoY-11.8%
1.16B
YoY-12.9%
1.33B
YoY+63.6%
813M
YoY-11.1%
915M
YoY+142.1%
2.37B
YoY-23.0%
3.08B
YoY-34.5%
4.70B
YoY-64.7%
13.3B
YoY+473.0%
2.32B
YoY+115.7%
$1.61
YoY-34.0%
$2.44
YoY-37.4%
$3.90
YoY-68.5%
$12.40
YoY+684.8%
$1.58
YoY+109.3%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
8.83B
YoY-2.7%
9.07B
YoY+8.3%
8.38B
YoY-5.8%
8.89B
YoY-13.0%
10.2B
YoY+15.8%
84.2B
YoY-1.5%
85.4B
YoY+15.5%
74.0B
YoY+1.9%
72.6B
YoY-3.2%
75.0B
YoY-6.3%
9.43B
YoY-1.0%
9.52B
YoY+4.1%
9.15B
YoY+17.9%
7.76B
YoY-6.8%
8.32B
YoY+1.2%
Long-term debt
20.6B
YoY-17.4%
25.0B
YoY+34.8%
18.5B
YoY-5.8%
19.7B
YoY-33.2%
29.4B
YoY-17.7%
Non-current lease liability
605M
YoY+29.0%
469M
YoY-35.5%
727M
YoY+10.7%
657M
YoY+12.3%
585M
YoY-8.7%
Deferred tax liabilities
5.64B
YoY+4.5%
5.39B
YoY-6.4%
5.76B
YoY+4.6%
5.51B
YoY-21.7%
7.04B
YoY-1.0%
Other non-current liabilities
7.31B
YoY+4.0%
7.03B
YoY+85.9%
3.78B
YoY+13.5%
3.33B
YoY+5.5%
3.16B
YoY+5.3%
36.0B
YoY+5.5%
34.2B
YoY+12.9%
30.3B
YoY+0.5%
30.1B
YoY+48.0%
20.3B
YoY+9.4%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
10.5B
YoY-7.9%
11.4B
YoY-7.1%
12.3B
YoY-26.8%
16.8B
YoY+61.1%
10.4B
YoY+163.8%
-5.80B
YoY+60.3%
-14.6B
YoY-109.0%
-6.98B
YoY-43.3%
-4.87B
YoY-288.8%
-1.25B
YoY-53.0%
-4.84B
YoY-226.0%
3.84B
YoY+178.6%
-4.89B
YoY+64.3%
-13.7B
YoY-60.0%
-8.57B
YoY-89.8%
Net change in cash
-111M
YoY-116.0%
693M
YoY+58.2%
438M
YoY+124.6%
-1.78B
YoY-391.8%
609M
YoY+144.1%
Interest paid
1.25B
YoY+18.8%
1.05B
YoY+3.4%
1.02B
YoY-28.6%
1.43B
YoY-15.4%
1.69B
YoY+10.8%
Income taxes paid
1.24B
YoY+18.8%
1.04B
YoY+0.0%
1.04B
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
40.5B
YoY-12.6%
46.4B
YoY-11.8%
52.6B
YoY-8.2%
57.3B
YoY+111.5%
27.1B
YoY+68.0%
P/E
17.1×
YoY+13.5%
15.1×
YoY+55.5%
9.7×
YoY+118.6%
4.4×
YoY-62.0%
11.7×
P/S
1.9×
YoY-8.0%
2.0×
YoY+13.8%
1.8×
YoY+11.9%
1.6×
YoY+53.7%
1.0×
YoY+10.8%
P/B
1.1×
YoY-17.2%
1.4×
YoY-24.3%
1.8×
YoY-10.0%
2.0×
YoY+49.7%
1.3×
YoY+53.5%
P/FCF
9.9×
YoY+10.2%
9.0×
YoY+15.8%
7.7×
YoY+62.3%
4.8×
YoY+33.1%
3.6×
YoY-68.5%
Earnings yield
5.8%
YoY-11.9%
6.6%
YoY-35.7%
10.3%
YoY-54.2%
22.6%
YoY+163.0%
8.6%
FCF yield
10.1%
YoY-9.2%
11.2%
YoY-13.7%
12.9%
YoY-38.4%
21.0%
YoY-24.9%
27.9%
YoY+217.1%
Dividend yield
2.3%
YoY+31.1%
1.8%
YoY+47.7%
1.2%
YoY+46.1%
0.8%
YoY+498.3%
0.1%
YoY-97.1%
Source filing10-K10-K10-K10-K10-K

About this data

Source: OXY's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all OXY filings on SEC EDGAR → Not investment advice.